Transcatheter Interventions Online 2022 - On Demand
Published: 09 March 2022
57m 43sPart 2 | Session 2 Session 2.2: Live Cases and Discussion
1h 1m 32sPart 2 | Session 4 Session 2.3: Practical Pearls Towards a More Advanced CTO Programme
56m 37sPart 2 | Session 5 Session 2.4: Live Cases and Discussion
45m 31sPart 2 | Session 7 BREAKOUT: Coronary Physiology in STEMI patients today: Why? When? How?
1h 1m 7sPart 1 | Session 1 Session 1.1: Next Level Structural Heart Interventions Nicolas M Van Mieghem, Kendra J Grubb, Lars Søndergaard, Azeem Latib, David Hildick-Smith
1h 2m 19sPart 1 | Session 2 Session 1.2: Live Cases and Discussion Lars Søndergaard, Ole De Backer, Holger Thiele, Nicolas M Van Mieghem, Azeem Latib, Kendra J Grubb, David Hildick-Smith, Mohamed Abdel-Wahab
45m 54sPart 1 | Session 3 Symposium: Optimising Outcomes for the TAVI Patient: Key Considerations for First Valve Choice and Implantation Techniques Didier Tchétché, Lars Søndergaard, Ran Kornowski, Douglas G Fraser
59m 47sPart 1 | Session 4 Session 1.3: Practical Perspectives in the Context of TAVI Kendra J Grubb, Didier Tchétché, Roxana Mehran, David Hildick-Smith, Lars Søndergaard
1h 2m 44sPart 1 | Session 5 Session 1.4: Live Cases and Discussions Nicolas M Van Mieghem, Susheel Kodali, Kendra J Grubb, Roxana Mehran, Didier Tchétché, David Hildick-Smith, Lars Søndergaard
44m 31sPart 1 | Session 6 BREAKOUT: Current Data and Future Direction in LAAC Ole De Backer, Dabit Arzamendi
48m 20sPart 1 | Session 7 BREAKOUT: Key Considerations to Ensure Long-Term Patients’ Outcomes: When Anatomy, Engineering and Clinical Practice Come Together David Smith, Andrew Cook
Following on from the success of 2021's inaugural edition, Transcatheter Interventions Online 2022 brings together a world-class faculty to provide expert insight and educational learning on the latest developments in interventional management.
Combining expert opinion and discussion, presentations, and live cases from centres on both sides of the Atlantic, TIO 2022 delivers best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
Note, the live version of this session was CME accredited; this on-demand version is not.
Key Learning Objectives
- Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
- Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
- Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
- Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
- Discuss the need for gender-specific trials and renal denervation
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Day One: Structural Heart Disease
Day Two: Coronary Heart Disease: High Risk & Complex PCI
Day Three: Debates and Controversies
Ajay J Kirtane
Professor of Clinical Medicine
Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.
In addition to his clinical commitments, Ajay has a strong interest in clinical education and research, serving as Chief Academic Officer of Columbia Interventional Cardiovascular Care. He is a director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Ajay’s research…
Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Margaret B McEntegart
Director of Complex PCI and CTO Programmes
Dr Margaret McEntegart serves as the Director of Complex PCI and CTO programmes at Columbia University Irving Medical Center, New York, US. She also holds the role of Director of Cardiac Catheterization Laboratories at Columbia University Irving Medical Center / New York-Presbyterian Hospital.
Before joining Columbia, Dr McEntegart served as a consultant interventional cardiologist at Golden Jubilee National Hospital (UK), where she played a pivotal role in establishing and leading the CTO and Complex PCI Programme.
Section Head of Interventional Cardiology
Dr Mohamed Azeem Latib is a world-leading expert in Interventional Cardiology. Dr Latib is the Section Head and Director of Interventional Cardiology as well as the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart and Vascular Care.
He is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).
His focus is on complex coronary interventions as well as transcatheter aortic, mitral and tricuspid interventions. His main clinical interests include Complex Coronary Interventions, Structural Heart Disease and New Device Innovation. He has extensive clinical experience in TAVR and MitraClip, as well as expertise in novel and new devices to treat mitral and tricuspid valve disease minimally invasively without open-heart surgery.
Dr Latib is currently involved in the development of the NeoChord NeXuS Transcatheter Mitral Chordal…
Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004. From 2004 to 2005, he completed a 12-month fellowship period in the Hemodynamic and Interventional Cardiology department of Clinique Pasteur in Toulouse and from 2005 to 2007 he was Head Assistant at the intensive care unit of Bichât Hospital in Paris.
In 2008, he joined the interventional cardiovascular group in Clinique Pasteur, Toulouse, and he is currently Head of the Structural programme with an experience of more than 5000 TAVI procedures. His main areas of interest are coronary interventions and valvular heart disease. He has been actively involved in many clinical trials involving new technologies and devices in the field of interventional cardiology.